Website Search
Find information on spaces, staff, and services.
Catalog Search
Books
Antimicrobial activity of nanoparticles : applications in wound healing and infection treatment
- Author / Creator
- Available as
- Online
Details
- Creator
- Gregory Guisbiers
- Format
- Books
- Language
- English
- Publication
-
- Amsterdam, Netherlands ; Kidlington, Oxford ; Cambridge, Massachusetts : Elsevier, [2023]
- ©2023
- Series
- Physical Details
-
- 1 online resource (302 pages)
- ISBNs
- 9780128216385, 9780128216378, 0128216387, 0128216379
- OCLC
- on1343246194
- Includes bibliographical references and index.
- Intro -- Antimicrobial Activity of Nanoparticles: Applications in Wound Healing and Infection Treatment -- Copyright -- Contents -- Contributors -- Preface -- Chapter 1: Targeting the main responsible of human infections with nanoparticles -- 1. Introduction -- 2. Bacterial infections -- 3. Viral infections -- 4. Fungal infections -- 5. Emerging infectious diseases and pathogens -- References -- Chapter 2: Nanomaterials to aid wound healing and infection control -- 1. Introduction -- 1.1. Wound healing -- 1.2. Bacterial infection control in wound healing -- 1.3. Nanomedicine for bacterial infection control -- 2. Metal nanoparticles for infection control in wound healing -- 2.1. Monometallic noble metal nanoparticles (Au, Ag, Pd, Pt) -- 2.1.1. Silver nanoparticles (AgNPs) -- 2.1.2. Gold nanoparticles (AuNPs) -- 2.1.3. Palladium nanoparticles (PdNPs) -- 2.1.4. Platinum nanoparticles (PtNPs) -- 2.2. Bimetallic nanoparticles -- 3. Nonmetal nanoparticles -- 3.1. Carbon-based nanomaterials -- 3.2. Polymeric nanoparticles -- 3.3. Lipid-based nanoparticles -- 4. Conclusion -- Acknowledgments -- References -- Chapter 3: Nanocomposite scaffolds and coatings for wound healing and infection control -- 1. Introduction: Coatings and scaffolds-Another way nanotechnology can influence infection control -- 2. Hydrogels -- 3. Nanofibers -- 4. Films -- 5. Nanocoatings -- 6. Conclusion and future directions -- Acknowledgments -- References -- Chapter 4: Antiviral potential of nanomaterials: The fight against viruses -- 1. Introduction -- 2. Metallic nanoparticles -- 2.1. Gold NPs -- 2.2. Silver NPs -- 2.3. Other metal NPs -- 3. Carbon nanomaterials -- 3.1. Graphene -- 3.2. Carbon dots -- 3.3. Fullerene -- 3.4. Carbon nanohorns -- 4. Conclusions -- References -- Chapter 5: Antiviral potential of nanomaterials: Novel solutions for emerging challenges
- 1. Introduction -- 2. Polymer-based nanogels -- 3. Liposomes -- 4. Nanobodies -- 5. Limitations -- 6. Conclusions and future perspectives -- References -- Chapter 6: Antimicrobial nanoparticles: Synthesis, mechanism of actions -- 1. Introduction -- 2. Synthesis -- 3. Mechanism -- 4. Metal oxide nanoparticles -- 4.1. Zinc oxide nanoparticles (ZnO) -- 4.2. Titanium dioxide nanoparticles (TiO2) -- 4.3. Magnesium oxide nanoparticles (MgO) -- 4.4. Copper oxide nanoparticles (CuO) -- 4.5. Cerium oxide nanoparticles -- 4.6. Iron oxide nanoparticles (IO NP) -- 4.7. Cobalt oxide nanoparticles (Co3O4) -- 5. Metal nanoparticles -- 5.1. Silver nanoparticles -- 5.2. Gold nanoparticles -- 5.3. Copper nanoparticles -- 5.4. Gallium nanoparticles -- 6. Discussion and conclusion -- Acknowledgment -- References -- Chapter 7: Surface functionalization of nanoparticles: Structure determines function -- 1. General aspects -- 2. Methods to functionalize and characterize nanoparticles for biomedical applications -- 2.1. Ligand exchange to improve nanoparticles physiological stability -- 2.2. Polarity and surface charge modification to enhance drug loading and cell adhesion -- 2.3. Ligands and other molecules to improve nanoparticles biocompatibility in living organisms -- 2.3.1. Polymers to increase biocompatibility of metallic and metallic oxide nanoparticles -- 2.3.2. Incorporation of polymers (PEG, PAH, etc.) to increase residence time in blood for organic nanoparticles (e.g., li ... -- 3. Bioconjugation for single and dual targeting in biomedical applications -- 3.1. Antibodies -- 3.2. Peptides -- 3.3. Vitamins -- 3.4. Aptamers -- 4. Conclusions and perspectives -- References -- Chapter 8: Toxicity of nanoparticles -- 1. Introduction -- 2. The physicochemical properties of nanoparticles (NPs) of biomedical importance -- 2.1. Size and polydispersity
- 2.2. Surface functionalization -- 2.3. Stability in the exposition media or biological fluids -- 3. Interactions of NMs and living organisms -- 3.1. Exposure routes -- 3.1.1. Intravenous route (i.v.) -- 3.1.2. Oral route -- 3.1.3. Dermal route -- 3.1.4. Respiratory route -- 3.2. Interaction of NMs with MOs -- 3.2.1. Efficiency as antibacterial agents -- 3.2.2. Efficiency as antifungal agents -- 3.2.3. Efficiency as antiviral agents -- 4. Toxicity of NPs -- 4.1. In vitro toxicity of NMs -- 4.2. In vivo toxicity of NMs -- 5. Toxicity effects of biomedical relevant NPs -- 5.1. Metallic NPs -- 5.2. Metal oxide NPs -- 5.3. Carbon NPs -- 6. Standardization of nanotoxicity evaluation: Future and challenges -- 7. Concluding remarks -- References -- Index
Subjects
- Infection -- Treatment.
- Nanomedicine.
- Wounds and injuries -- Treatment.
- Nanoparticles
Medical Subject Heading
- Nanoparticles -- therapeutic use
Medical Subject Heading
- Anti-Infective Agents
Medical Subject Heading
- Wounds and Injuries -- therapy
Medical Subject Heading
- Wounds and Injuries -- drug therapy
Medical Subject Heading